Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT05082077

Global Utilization And Registry Database for Improved preservAtion of doNor Livers

Sponsor: Paragonix Technologies

View on ClinicalTrials.gov

Summary

The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor liver that were preserved and transported within the LIVERguard system, as well as retrospective standard of care patients

Official title: Global Utilization and Registry Database for Improved Preservation of Donor Livers

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

1000

Start Date

2022-03-15

Completion Date

2028-01

Last Updated

2025-05-15

Healthy Volunteers

No

Interventions

DEVICE

LIVERguard

The LIVERguard is an FDA cleared and is a CE-marked medical device intended to be used for the static hypothermic preservation of livers during transportation and eventual transplantation into a recipient using cold storage solutions indicated for use with the liver. The intended organ storage time for the LIVERguard is up to 16 hours.

Locations (7)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Stanford University

Stanford, California, United States

University of Florida

Gainesville, Florida, United States

Tampa General Hospital

Tampa, Florida, United States

University of Nebraska

Omaha, Nebraska, United States

Duke University

Durham, North Carolina, United States

University of Washington

Seattle, Washington, United States